Subscribe to Newsletter

Business & Regulation


Business & Regulation Bioprocessing - Upstream & Downstream

Trump Administration Cans Bird Flu Vaccine Contract With Moderna

| Rob Coker | 3 min read

From bird flu to COVID-19 vaccines to alleged corruption in journals, we look into recent moves from US Health Secretary RFK Jr.

Business & Regulation Business Practice

This Week’s Biopharma News: Pfizer and Astellas Drug Improves Cancer Survival

| Rob Coker | 4 min read

Our latest news roundup reports on a new blow for Harvard, how Pfizer and Astellas’ Xtandi improves cancer survival, and more.

Business & Regulation Business Practice

Behind the Scenes of a GMP Win

| 4 min read

We ask a company about lessons learned from the GMP certification process.

Business & Regulation Business Practice

The New Age of Global, Political, and Regulatory Challenges

| 7 min read

A report attempts to unravel the many challenges that face business leaders. We discuss those inherent in the pharmaceutical industry.

Business & Regulation Business Practice

What Trump’s Latest Moves Mean for the Industry

| 6 min read

Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”

Business & Regulation Standards & Regulation

This Week’s Industry News: Changes at the top of Novo Nordisk

| 3 min read

Our latest news roundup reports on changes at Novo Nordisk, AbbVie’s ADC accelerated approval, Regeneron’s new acquisition, and more.

Business & Regulation Business Practice

The Challenges and Successes of A Biotech Startup

| Dan Williams | 3 min read

Discussing the challenges facing small rare disease-focussed biotechs, and the successes of advancing treatments.

Business & Regulation Profession

Life Through A Scientific Lens

| 6 min read

From academia in Milan to professional development in the UK, Valo Therapeutics CEO Marcella Origgi shares her journey.

Business & Regulation Bioprocessing - Upstream & Downstream

The Power List Personified: Getting to Know Beatrice Lavery

| Rob Coker | 4 min read

Now that the 2025 Power List is live, we speak with the people working hard every day to make a difference.

Business & Regulation Advanced Medicine

This Week’s Biopharma News: Long-Running CRISPR Patent Case Reopened

| Rob Coker | 4 min read

Our latest roundup reports on Trump's “most favored nation” order, an EMA investigation into finasteride, and Novo Nordisk’s continued R&D for obesity


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker